Wednesday, 30 January 2013

Czech Republic Pharmaceuticals and Healthcare Report Q1 2013

Business Monitor International Market Research Reports
Market Reports Online XML Feed

Czech Republic Pharmaceuticals and Healthcare Report Q1 2013
Jan 30th 2013, 00:00
BMI View: The recent measures proposed by the Czech Republic''s Ministry of Health will, in alllikelihood, negatively affect the Czech pharmaceutical market. The introduction of reimbursementceilings, blind bidding auctions and preferential prescribing will squeeze drugmakers'' margins and shiftsome of the burden of healthcare spending onto the private sector. The outcome of similar measures inHungary and Poland strongly supports our view that the business environment for drugmakers willworsen if these proposals are adopted. It is patients who, ultimately, will suffer.Headline Expenditure Projections?? Pharmaceuticals: CZK80.71bn (US$4.56bn) in 2011 to CZK79.76bn...
Delicious Digg Evernote Facebook Google Bookmarks Google Plus LinkedIn StumbleUpon Tumblr Twitter
You are receiving this email because you subscribed to this feed at

If you no longer wish to receive these emails, you can unsubscribe from this feed, or manage all your subscriptions

No comments:

Post a Comment